Shares of Perrigo Company (NYSE: PRGO) rose over 20% this morning after the healthcare leader released second-quarter 2017 financial results and adjusted full-year 2017 guidance. While revenue slipped 8% from the year-ago period, that was mostly caused by its divesting from unprofitable businesses late last year. Adjusted for those divestitures, sales increased year over year.